ViewRay Inc
OTC:VRAYQ
ViewRay Inc
ViewRay, Inc. designs, manufactures and markets magnetic resonance imaging (MRI) system. The company is headquartered in Oakwood Village, Ohio and currently employs 267 full-time employees. The company went IPO on 2014-11-04. The MRIdian MR-Guided Radiation Therapy System integrates diagnostic MR imaging with radiation therapy delivery to enable on-table adaptive treatments with real-time tissue tracking and automatic beam gating. The MRIdian is comprised of three components, namely magnetic resonance imaging (MRI) system, radiation delivery system, and integrated treatment planning and delivery software. MRIdian employs MRI-based technology to provide real-time imaging that targets tumor from the surrounding soft tissue and other critical organs, both before and during radiation treatment delivery. MRIdian offers MR-guided imaging that provides tissue visualization compared to cone-beam computed tomography (CBCT), to enable contouring and reduced margins. The firm has installed approximately 48 MRIdian systems at hospitals, which are used to treat a variety of solid tumors.
ViewRay, Inc. designs, manufactures and markets magnetic resonance imaging (MRI) system. The company is headquartered in Oakwood Village, Ohio and currently employs 267 full-time employees. The company went IPO on 2014-11-04. The MRIdian MR-Guided Radiation Therapy System integrates diagnostic MR imaging with radiation therapy delivery to enable on-table adaptive treatments with real-time tissue tracking and automatic beam gating. The MRIdian is comprised of three components, namely magnetic resonance imaging (MRI) system, radiation delivery system, and integrated treatment planning and delivery software. MRIdian employs MRI-based technology to provide real-time imaging that targets tumor from the surrounding soft tissue and other critical organs, both before and during radiation treatment delivery. MRIdian offers MR-guided imaging that provides tissue visualization compared to cone-beam computed tomography (CBCT), to enable contouring and reduced margins. The firm has installed approximately 48 MRIdian systems at hospitals, which are used to treat a variety of solid tumors.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
